Stockreport

Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules [MarketWatch]

Pasithea Therapeutics Corp.  (KTTA) 
PDF Corp. (Nasdaq: KTTA; KTTAW) ("Pasithea" or the "Company"), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric [Read more]